Pharmaceutical Technology13 小时
SRD-002 by Sardocor for Diastolic Heart Failure (HFpEF): Likelihood of Approval
SRD-002 is under clinical development by Sardocor and currently in Phase II for Diastolic Heart Failure (HFpEF).